Literature DB >> 29131398

Response to Cognitive Processing Therapy in Veterans With and Without Obstructive Sleep Apnea.

Franklin Mesa1, Benjamin D Dickstein1, Virgil D Wooten2,3, Kathleen M Chard1,3.   

Abstract

Recent studies have called attention to the need for enhancing treatment outcome in trauma-focused psychotherapies, such as cognitive processing therapy (CPT), with veterans. Given the prevalence of posttraumatic-related sleep disturbances, and the role of sleep in emotional learning and processing, sleep quality may be a target for improving CPT outcome. Elevated rates of obstructive sleep apnea (OSA) have been reported in samples of veterans with posttraumatic stress disorder (PTSD); however, the impact of OSA on response to CPT is unclear. In this study, CPT outcome was examined in veterans with and without a diagnosis of OSA. Following chart review, 68 OSA-positive and 276 OSA-negative veterans were identified. Generalized estimating equations were used to compare between-group differences in weekly self-reported PTSD symptomatology. The OSA-positive veterans reported greater PTSD severity over the course of treatment and at posttreatment compared with veterans without OSA (B = -0.657). Additionally, OSA-positive veterans with access to continuous positive airway pressure (CPAP) therapy reported less PTSD severity relative to OSA-positive veterans without access to CPAP (B = -0.421). Apnea appears to be a contributing factor to the reduced effectiveness of evidence-based psychotherapy for veterans with PTSD; however, preliminary evidence indicates that CPAP therapy may help mitigate the impact of OSA on treatment outcome. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Year:  2017        PMID: 29131398     DOI: 10.1002/jts.22245

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  7 in total

Review 1.  More than sleepiness: prevalence and relevance of nonclassical symptoms of obstructive sleep apnea.

Authors:  Johan Verbraecken
Journal:  Curr Opin Pulm Med       Date:  2022-09-14       Impact factor: 2.868

2.  Sleep disorder symptoms are associated with greater posttraumatic stress and anger symptoms in US Army service members seeking treatment for posttraumatic stress disorder.

Authors:  Shannon R Miles; Kristi E Pruiksma; Danica Slavish; Jessica R Dietch; Sophie Wardle-Pinkston; Brett T Litz; Matthew Rodgers; Karin L Nicholson; Stacey Young-McCaughan; Katherine A Dondanville; Risa Nakase-Richardson; Jim Mintz; Terence M Keane; Alan L Peterson; Patricia A Resick; Daniel J Taylor
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

3.  Two Independent Predictors of Nightmares in Posttraumatic Stress Disorder.

Authors:  Katherine E Miller; Andrea L Jamison; Sasha Gala; Steven H Woodward
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

Review 4.  Recent Advancements in Treating Sleep Disorders in Co-Occurring PTSD.

Authors:  Peter J Colvonen; Laura D Straus; Carl Stepnowsky; Michael J McCarthy; Lizabeth A Goldstein; Sonya B Norman
Journal:  Curr Psychiatry Rep       Date:  2018-06-21       Impact factor: 5.285

5.  Diagnosing obstructive sleep apnea in a residential treatment program for veterans with substance use disorder and PTSD.

Authors:  Peter J Colvonen; Guadalupe L Rivera; Laura D Straus; Jae E Park; Moira Haller; Sonya B Norman; Sonia Ancoli-Israel
Journal:  Psychol Trauma       Date:  2021-09-02

6.  Changes in insomnia severity with advanced PAP therapy in patients with posttraumatic stress symptoms and comorbid sleep apnea: a retrospective, nonrandomized controlled study.

Authors:  Barry J Krakow; Natalia D McIver; Jessica J Obando; Victor A Ulibarri
Journal:  Mil Med Res       Date:  2019-05-09

7.  STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia: STOP-BANG does not sufficiently detect risk.

Authors:  Robert Lyons; Lara A Barbir; Robert Owens; Peter J Colvonen
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.